Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sanfeng Tongqiao Dripping Pills for Seasonal Allergic Rhinitis
CTR20241258Phase 2Terminated
- Sponsor
- Yangtze River Pharmaceutical Group
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Sanfeng Tongqiao Diwan in seasonal allergic rhinitis (SAR), sponsored by Yangtze River Pharmaceutical Group. Started Apr 2024; status: terminated.
02
Drugs
Sanfeng Tongqiao Diwan
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on CTR20241258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20241258.